Abstract

RationalePulmonary hypertension (PH) is a rare but fatal disease characterized by elevated pulmonary pressures and vascular remodeling, leading to right ventricular failure and death. Recently, neuroinflammation has been suggested to be involved in the sympathetic activation in experimental PH. Whether PH is associated with neuroinflammation in the spinal cord has never been investigated.Methods/ResultsPH was well-established in adult male Wistar rats 3-week after pulmonary endothelial toxin Monocrotaline (MCT) injection. Using the thoracic segments of the spinal cord, we found a 5-fold increase for the glial fibrillary acidic protein (GFAP) in PH rats compared to controls (p < 0.05). To further determine the region of the spinal cord where GFAP was expressed, we performed immunofluorescence and found a 3 to 3.5-fold increase of GFAP marker in the gray matter, and a 2 to 3-fold increase in the white matter in the spinal cord of PH rats compared to controls. This increase was due to PH (MCT vs. Control; p < 0.01), and there was no difference between the dorsal versus ventral region. PH rats also had an increase in the pro-inflammatory marker chemokine (C-C motif) ligand 3 (CCL3) protein expression (∼ 3-fold) and (2.8 to 4-fold, p < 0.01) in the white matter. Finally, angiogenesis was increased in PH rat spinal cords assessed by the adhesion molecule CD31 expression (1.5 to 2.3-fold, p < 0.01).ConclusionWe report for the first time evidence for neuroinflammation in the thoracic spinal cord of pulmonary hypertensive rats. The impact of spinal cord inflammation on cardiopulmonary function in PH remains elusive.

Highlights

  • Pulmonary arterial hypertension (PAH) is a rare but fatal disease characterized by elevated pulmonary vascular pressure and pulmonary arterial remodeling, leading to right ventricular failure and patient’s death

  • Several studies described an activation of the sympathetic nervous system in PAH patients, which was Pulmonary Hypertension and Neuroinflammation associated with clinical worsening and poor outcome (VelezRoa et al, 2004; Dimopoulos et al, 2009; Wensel et al, 2009; Ciarka et al, 2010; Mak et al, 2012; Witte et al, 2016)

  • Pulmonary hypertension in MCT-treated rats was confirmed by increased right ventricle (RV) pressure and pulmonary vascular remodeling (Figures 1B,C)

Read more

Summary

Conclusion

We report for the first time evidence for neuroinflammation in the thoracic spinal cord of pulmonary hypertensive rats.

INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call